Erik Roberson - Publications

Affiliations: 
Neurology & Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Neurodegenerative Disease
Website:
http://labs.uab.edu/erobers

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Roberson ED, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2  0.52
2018 Arrant AE, Filiano AJ, Patel AR, Hoffmann MQ, Boyle NR, Kashyap SN, Onyilo VC, Young AH, Roberson ED. Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice. Neurobiology of Disease. PMID 30448285 DOI: 10.1016/j.nbd.2018.11.011  0.96
2018 Arrant AE, Nicholson AM, Zhou X, Rademakers R, Roberson ED. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Molecular Neurodegeneration. 13: 32. PMID 29929528 DOI: 10.1186/s13024-018-0264-6  0.96
2018 Arrant AE, Onyilo VC, Unger DE, Roberson ED. Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29378861 DOI: 10.1523/JNEUROSCI.3081-17.2018  0.96
2017 Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan I. Genetic influences on cognition in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29076559 DOI: 10.1002/mds.27196  0.36
2017 Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, et al. (18) F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study. Annals of Neurology. PMID 28980714 DOI: 10.1002/ana.25060  0.72
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Roberson ED, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/ng.3916  0.52
2017 Tomlinson JJ, Shutinoski B, Dong L, Meng F, Elleithy D, Lengacher NA, Nguyen AP, Cron GO, Jiang Q, Roberson ED, Nussbaum RL, Majbour NK, El-Agnaf OM, Bennett SA, Lagace DC, et al. Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28477284 DOI: 10.1007/s00702-017-1726-7  0.36
2017 Arrant AE, Filiano AJ, Unger DE, Young AH, Roberson ED. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia. Brain : a Journal of Neurology. PMID 28379303 DOI: 10.1093/brain/awx060  0.96
2016 Natelson Love M, Clark DG, Cochran JN, Den Beste KA, Geldmacher DS, Benzinger TL, Gordon BA, Morris JC, Bateman RJ, Roberson ED. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease. Neurobiology of Aging. PMID 27793474 DOI: 10.1016/j.neurobiolaging.2016.09.020  0.76
2016 Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, Darwish SM, Van Berlo V, Barnes DE, Mantle M, Karydas AM, Coppola G, Roberson ED, Miller BL, Garcia PA, et al. Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease. Annals of Neurology. PMID 27696483 DOI: 10.1002/ana.24794  1
2016 Arrant AE, Filiano AJ, Warmus BA, Hall AM, Roberson ED. Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test. Genes, Brain, and Behavior. PMID 27213486 DOI: 10.1111/gbb.12300  0.96
2015 Kimbrough IF, Robel S, Roberson ED, Sontheimer H. Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease. Brain : a Journal of Neurology. 138: 3716-33. PMID 26598495 DOI: 10.1093/brain/awv327  1
2015 Arrant AE, Patel AR, Roberson ED. Effects of Exercise on Progranulin Levels and Gliosis in Progranulin-Insufficient Mice. Eneuro. 2. PMID 26361634 DOI: 10.1523/ENEURO.0061-14.2015  0.96
2015 Cochran JN, Rush T, Buckingham SC, Roberson ED. The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity. Human Molecular Genetics. PMID 26358779 DOI: 10.1093/hmg/ddv371  0.76
2015 Gannon M, Che P, Chen Y, Jiao K, Roberson ED, Wang Q. Noradrenergic dysfunction in Alzheimer's disease. Frontiers in Neuroscience. 9: 220. PMID 26136654 DOI: 10.3389/fnins.2015.00220  1
2015 Hall AM, Throesch BT, Buckingham SC, Markwardt SJ, Peng Y, Wang Q, Hoffman DA, Roberson ED. Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 6221-30. PMID 25878292 DOI: 10.1523/JNEUROSCI.2552-14.2015  1
2015 Day JJ, Roberson ED. DNA methylation slows effects of C9orf72 mutations: An epigenetic brake on genetic inheritance. Neurology. 84: 1616-7. PMID 25795647 DOI: 10.1212/WNL.0000000000001504  1
2014 Arrant AE, Roberson ED. MicroRNA-124 modulates social behavior in frontotemporal dementia. Nature Medicine. 20: 1381-3. PMID 25473917 DOI: 10.1038/nm.3768  1
2014 Warmus BA, Sekar DR, McCutchen E, Schellenberg GD, Roberts RC, McMahon LL, Roberson ED. Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 16482-95. PMID 25471585 DOI: 10.1523/JNEUROSCI.3418-14.2014  1
2014 Cochran JN, Diggs PV, Nebane NM, Rasmussen L, White EL, Bostwick R, Maddry JA, Suto MJ, Roberson ED. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease. Journal of Biomolecular Screening. 19: 1338-49. PMID 25156556 DOI: 10.1177/1087057114547232  1
2014 Ward ME, Taubes A, Chen R, Miller BL, Sephton CF, Gelfand JM, Minami S, Boscardin J, Martens LH, Seeley WW, Yu G, Herz J, Filiano AJ, Arrant AE, Roberson ED, et al. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. The Journal of Experimental Medicine. 211: 1937-45. PMID 25155018 DOI: 10.1084/jem.20140214  1
2014 Li Z, Hall AM, Kelinske M, Roberson ED. Seizure resistance without parkinsonism in aged mice after tau reduction. Neurobiology of Aging. 35: 2617-24. PMID 24908165 DOI: 10.1016/j.neurobiolaging.2014.05.001  1
2014 Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, ... Roberson ED, et al. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. The Lancet. Neurology. 13: 676-85. PMID 24873720 DOI: 10.1016/S1474-4422(14)70088-2  1
2014 Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, ... Roberson ED, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. The Journal of Clinical Investigation. 124: 981-99. PMID 24509083 DOI: 10.1172/JCI72723  1
2014 Cochran JN, Hall AM, Roberson ED. The dendritic hypothesis for Alzheimer's disease pathophysiology. Brain Research Bulletin. 103: 18-28. PMID 24333192 DOI: 10.1016/j.brainresbull.2013.12.004  1
2013 Filiano AJ, Martens LH, Young AH, Warmus BA, Zhou P, Diaz-Ramirez G, Jiao J, Zhang Z, Huang EJ, Gao FB, Farese RV, Roberson ED. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 5352-61. PMID 23516300 DOI: 10.1523/JNEUROSCI.6103-11.2013  1
2013 Seward ME, Swanson E, Norambuena A, Reimann A, Cochran JN, Li R, Roberson ED, Bloom GS. Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease. Journal of Cell Science. 126: 1278-86. PMID 23345405 DOI: 10.1242/jcs.1125880  1
2013 Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, ... ... Roberson ED, et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 189-98. PMID 23062850 DOI: 10.1016/j.jalz.2012.03.003  1
2013 Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, et al. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 176-88. PMID 23043900 DOI: 10.1016/j.jalz.2012.03.002  1
2012 Roberson ED. Mouse models of frontotemporal dementia. Annals of Neurology. 72: 837-49. PMID 23280835 DOI: 10.1002/ana.23722  1
2012 Jin YN, Chen PC, Watson JA, Walters BJ, Phillips SE, Green K, Schmidt R, Wilson JA, Johnson GV, Roberson ED, Dobrunz LE, Wilson SM. Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits. Plos One. 7: e47884. PMID 23144711 DOI: 10.1371/journal.pone.0047884  1
2012 Roberson ED, Defazio RA, Barnes CA, Alexander GE, Bizon JL, Bowers D, Foster TC, Glisky EL, Levin BE, Ryan L, Wright CB, Geldmacher DS. Challenges and opportunities for characterizing cognitive aging across species. Frontiers in Aging Neuroscience. 4: 6. PMID 22988434 DOI: 10.3389/fnagi.2012.00006  1
2012 Hall AM, Roberson ED. Mouse models of Alzheimer's disease. Brain Research Bulletin. 88: 3-12. PMID 22142973 DOI: 10.1016/j.brainresbull.2011.11.017  1
2011 Roberson ED, Hope OA, Martin RC, Schmidt D. Geriatric epilepsy: research and clinical directions for the future. Epilepsy & Behavior : E&B. 22: 103-11. PMID 21596624 DOI: 10.1016/j.yebeh.2011.04.005  1
2011 Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L. Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 700-11. PMID 21228179 DOI: 10.1523/JNEUROSCI.4152-10.2011  1
2011 Palop JJ, Mucke L, Roberson ED. Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling. Methods in Molecular Biology (Clifton, N.J.). 670: 245-62. PMID 20967595 DOI: 10.1007/978-1-60761-744-0_17  1
2011 Palop JJ, Roberson ED, Cobos I. Step-by-step in situ hybridization method for localizing gene expression changes in the brain. Methods in Molecular Biology (Clifton, N.J.). 670: 207-30. PMID 20967593 DOI: 10.1007/978-1-60761-744-0_15  1
2011 Roberson ED. Contemporary approaches to Alzheimer's disease and frontotemporal dementia. Methods in Molecular Biology (Clifton, N.J.). 670: 1-9. PMID 20967579 DOI: 10.1007/978-1-60761-744-0_1  1
2011 Roberson ED. Preface Methods in Molecular Biology. 670: v.  1
2010 Rabinovici GD, Roberson ED. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease. Annals of Neurology. 67: 283-5. PMID 20373338 DOI: 10.1002/ana.22020  1
2009 Wacker JL, Huang SY, Steele AD, Aron R, Lotz GP, Nguyen Q, Giorgini F, Roberson ED, Lindquist S, Masliah E, Muchowski PJ. Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9104-14. PMID 19605647 DOI: 10.1523/JNEUROSCI.2250-09.2009  1
2009 Roberson ED, Kao AW. Animal models of dementia The Behavioral Neurology of Dementia. 131-141. DOI: 10.1017/CBO9780511581410.010  1
2008 Meilandt WJ, Yu GQ, Chin J, Roberson ED, Palop JJ, Wu T, Scearce-Levie K, Mucke L. Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 5007-17. PMID 18463254 DOI: 10.1523/JNEUROSCI.0590-08.2008  1
2008 Scearce-Levie K, Roberson ED, Gerstein H, Cholfin JA, Mandiyan VS, Shah NM, Rubenstein JL, Mucke L. Abnormal social behaviors in mice lacking Fgf17. Genes, Brain, and Behavior. 7: 344-54. PMID 17908176 DOI: 10.1111/j.1601-183X.2007.00357.x  1
2007 Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 55: 697-711. PMID 17785178 DOI: 10.1016/j.neuron.2007.07.025  1
2007 Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science (New York, N.Y.). 316: 750-4. PMID 17478722 DOI: 10.1126/science.1141736  1
2006 Roberson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science (New York, N.Y.). 314: 781-4. PMID 17082448 DOI: 10.1126/science.1132813  1
2006 Roberson ED. Frontotemporal dementia. Current Neurology and Neuroscience Reports. 6: 481-9. PMID 17074283 DOI: 10.1007/s11910-006-0050-7  1
2006 Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron. 51: 703-14. PMID 16982417 DOI: 10.1016/j.neuron.2006.07.027  1
2005 Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, Forman MS, Miller CA, Trojanowski JQ, Kramer JH, Miller BL. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 65: 719-25. PMID 16157905 DOI: 10.1212/01.wnl.0000173837.82820.9f  1
2005 Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, Chute DJ, Roberson ED, Pace-Savitsky C, Neumann M, Chow TW, Rosen HJ, Forstl H, Kurz A, Miller BL. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Archives of Neurology. 62: 925-30. PMID 15956163 DOI: 10.1001/archneur.62.6.925  1
2003 Nakamura K, Roberson ED, Reilly LG, Tsao JW. Polyneuropathy following gastric bypass surgery. The American Journal of Medicine. 115: 679-80. PMID 14656629 DOI: 10.1016/j.amjmed.2003.05.002  1
2001 Roberson ED, Sweatt JD. Memory-forming chemical reactions. Reviews in the Neurosciences. 12: 41-50. PMID 11236064  1
2000 Adams JP, Roberson ED, English JD, Selcher JC, Sweatt JD. MAPK regulation of gene expression in the central nervous system. Acta Neurobiologiae Experimentalis. 60: 377-94. PMID 11016081  1
1999 Roberson ED, Sweatt JD. A biochemical blueprint for long-term memory. Learning & Memory (Cold Spring Harbor, N.Y.). 6: 381-8. PMID 10509708  1
1999 Roberson ED, English JD, Adams JP, Selcher JC, Kondratick C, Sweatt JD. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 4337-48. PMID 10341237  1
1998 Sweatt JD, Atkins CM, Johnson J, English JD, Roberson ED, Chen SJ, Newton A, Klann E. Protected-site phosphorylation of protein kinase C in hippocampal long-term potentiation. Journal of Neurochemistry. 71: 1075-85. PMID 9721732  1
1998 Matilla A, Roberson ED, Banfi S, Morales J, Armstrong DL, Burright EN, Orr HT, Sweatt JD, Zoghbi HY, Matzuk MM. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5508-16. PMID 9651231  1
1998 Klann E, Roberson ED, Knapp LT, Sweatt JD. A role for superoxide in protein kinase C activation and induction of long-term potentiation. The Journal of Biological Chemistry. 273: 4516-22. PMID 9468506 DOI: 10.1074/jbc.273.8.4516  1
1996 Roberson ED, English JD, Sweatt JD. A biochemist's view of long-term potentiation. Learning & Memory (Cold Spring Harbor, N.Y.). 3: 1-24. PMID 10456072  1
1996 Roberson ED, Sweatt JD. Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation. The Journal of Biological Chemistry. 271: 30436-41. PMID 8940008 DOI: 10.1074/jbc.271.48.30436  1
1995 Roberson ED, Sweatt JD. Regulation of adenylyl cyclase in LTP Behavioral and Brain Sciences. 18: 485-486.  1
1992 Sessoms JS, Chen SJ, Chetkovich DM, Powell CM, Roberson ED, Sweatt JD, Klann E. Ca(2+)-induced persistent protein kinase C activation in rat hippocampal homogenates. Second Messengers and Phosphoproteins. 14: 109-26. PMID 1345337  1
Show low-probability matches.